Amanda L. Gross

GLYX-13, a NMDA Receptor Glycine-Site Functional Partial Agonist, Induces Antidepressant-Like Effects Without Ketamine-Like Side Effects

Jeffrey Burgdorf, Xiaolei Zhang, Katherine L. Nicholson et al. · Neuropsychopharmacology · 2012 · 282 citations · Full text

Medicine, Neuroscience, Pharmacology +14

The long-lasting antidepressant effects of rapastinel (GLYX-13) are associated with a metaplasticity process in the medial prefrontal cortex and hippocampus

Jeffrey Burgdorf, X.-l. Zhang, Craig Weiss et al. · Neuroscience · 2015 · 85 citations

Life Sciences, Neuroscience, Pharmacology +16

Rapastinel (GLYX-13) has therapeutic potential for the treatment of post-traumatic stress disorder: Characterization of a NMDA receptor-mediated metaplasticity process in the medial prefrontal cortex of rats

Jeffrey Burgdorf, Roger A. Kroes, Xiao-lei Zhang et al. · Behavioural Brain Research · 2015 · 58 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Polyethylene glycol-b-poly(lactic acid) Polymersomes As Vehicles for Enzyme Replacement Therapy

Jessica M. Kelly, Amanda L. Gross, Douglas R. Martin et al. · Nanomedicine · 2017 · 50 citations

Pharmacy, Biotechnology, Pharmaceutics +15

NYX-2925 Is a Novel NMDA Receptor-Specific Spirocyclic-β-Lactam That Modulates Synaptic Plasticity Processes Associated with Learning and Memory

M. Amin Khan, David R. Houck, Amanda L. Gross et al. · The International Journal of Neuropsychopharmacology · 2017 · 50 citations · Full text

Life Sciences, Neuroscience, Pharmacology +16